Apyx Medical Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 49.7% | 49.1% | 49.6% | 48.5% | 50.9% | 48.0% | 49.7% | 45.3% | 31.3% | 40.6% | 36.1% | 31.9% | 33.8% | 28.2% | 40.3% | 51.3% | 32.1% | 32.8% | 32.2% | 32.9% | 31.9% | 27.8% | 34.2% | 32.8% | 36.8% | 34.7% | 37.6% | 31.6% | 33.4% | 72.3% | 41.9% | 76.9% | 39.5% | 37.0% | 39.9% | 37.7% | 35.6% | 110.5% | 62.6% | 36.1% | 66.1% | |
| 50.3% | 50.9% | 50.4% | 51.5% | 49.1% | 52.0% | 50.3% | 54.7% | 68.7% | 59.4% | 63.9% | 68.1% | 66.2% | 71.8% | 59.7% | 48.7% | 67.9% | 67.2% | 67.8% | 67.1% | 68.1% | 72.2% | 65.8% | 67.2% | 63.2% | 65.3% | 62.4% | 68.4% | 66.6% | 27.7% | 58.1% | 23.1% | 60.5% | 63.0% | 60.1% | 62.3% | 64.4% | -10.5% | 37.4% | 63.9% | 33.9% | |
| 6.8% | 7.1% | 8.5% | 7.1% | 6.5% | 3.9% | 5.7% | 7.1% | 16.7% | 9.8% | 13.9% | 13.5% | 12.4% | 13.0% | 19.6% | 22.7% | 15.1% | 8.0% | 12.9% | 9.7% | 9.9% | 5.6% | 9.3% | 10.4% | 11.6% | 10.0% | 10.5% | 10.0% | 11.8% | 8.5% | 13.6% | 11.7% | 9.9% | 7.9% | 8.5% | 7.2% | 6.2% | 4.9% | 6.1% | 5.7% | 5.7% | |
| 46.0% | 54.8% | 62.6% | 57.7% | 54.8% | 44.3% | 53.4% | 49.9% | 128.1% | 124.1% | 139.3% | 122.5% | 115.9% | 129.0% | 190.0% | 169.6% | 115.7% | 77.1% | 109.9% | 93.5% | 91.7% | 76.7% | 103.5% | 114.8% | 115.0% | 102.4% | 98.1% | 87.3% | 93.6% | 91.8% | 109.0% | 95.6% | 82.2% | 76.6% | 83.9% | 77.7% | 11.5% | 57.6% | 64.6% | 71.2% | 52.2% | |
| 52.7% | 61.9% | 71.1% | 64.8% | 61.3% | 48.1% | 59.0% | 57.0% | 144.8% | 133.9% | 153.2% | 136.1% | 128.2% | 141.9% | 209.6% | 192.3% | 130.8% | 85.1% | 122.8% | 103.1% | 101.6% | 82.3% | 112.8% | 125.2% | 126.6% | 112.4% | 108.6% | 77.5% | 105.3% | 67.1% | 122.6% | 68.8% | 92.2% | 84.5% | 92.4% | 84.9% | 70.9% | -10.6% | 44.7% | 76.9% | 40.0% | |
| -2.4% | -11.0% | -20.7% | -13.3% | -12.1% | -9.6% | -8.7% | -2.3% | -76.1% | -86.9% | -89.4% | -68.0% | -62.0% | -70.1% | -149.9% | -143.6% | -62.9% | -17.9% | -54.9% | -36.0% | -33.5% | -10.1% | -47.0% | -58.1% | -63.4% | -47.0% | -46.2% | -9.1% | -38.7% | -39.4% | -64.6% | -45.7% | -31.6% | -21.4% | -32.4% | -22.6% | -6.5% | 0.1% | -7.3% | -13.0% | -6.1% | |
| 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.3% | 0.3% | 0.3% | 0.8% | 2.3% | 7.3% | 6.1% | 4.3% | 0.1% | 0.1% | 0.2% | 0.4% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% | 1.9% | 4.0% | 4.9% | 7.6% | 13.6% | 11.7% | 12.5% | 11.6% | 14.6% | 12.2% | 11.0% | 7.3% | 11.0% | 10.0% | 9.6% | |
| -9.6% | -4.8% | -20.0% | -13.3% | -13.3% | -8.8% | -9.3% | -2.3% | -77.5% | -79.6% | -82.5% | -64.9% | -54.7% | -71.6% | -137.2% | -143.9% | -64.0% | -16.8% | -56.0% | -35.1% | -35.2% | -11.2% | -47.2% | -52.0% | -63.0% | -46.9% | -47.8% | -7.0% | -41.7% | -65.0% | -73.6% | -53.8% | -40.6% | -32.1% | -43.7% | -32.4% | -14.6% | -6.0% | -16.0% | -21.2% | -13.6% | |
| 0.4% | 0.7% | 0.1% | 0.0% | 0.1% | -1.5% | 0.1% | 0.1% | -65.6% | -23.5% | -2.1% | 1.2% | 2.3% | -3.0% | -98.2% | -34.7% | -10.3% | -3.4% | 0.8% | 1.0% | 0.6% | 0.8% | 0.6% | 0.9% | 0.5% | 1.2% | -18.7% | 0.5% | -2.7% | 0.6% | 0.5% | 0.4% | 0.5% | 0.6% | 0.5% | 0.4% | 0.6% | 0.5% | 1.1% | 0.9% | 0.8% | |
| -9.6% | -5.5% | -20.1% | -13.3% | -13.3% | -7.3% | -9.4% | -2.4% | 1,883.8% | -66.8% | -80.4% | -66.0% | -56.9% | -68.6% | -39.0% | -109.2% | -53.6% | -13.3% | -56.7% | -36.0% | -35.7% | -11.9% | -47.6% | -52.7% | -63.2% | -48.0% | -28.7% | -7.3% | -38.7% | -65.5% | -74.0% | -54.0% | -40.9% | -32.5% | -44.0% | -33.2% | -15.4% | -6.8% | -16.9% | -23.4% | -14.8% | |
| -7.2% | -2.6% | -17.5% | -11.1% | -10.3% | -7.0% | -8.7% | -23.7% | -76.1% | -77.7% | -79.2% | -63.0% | -52.9% | -68.6% | -132.8% | -138.5% | -60.4% | -14.7% | -53.3% | -33.2% | -33.2% | -9.8% | -45.3% | -49.6% | -60.7% | -45.3% | -44.2% | -1.9% | -35.3% | -56.4% | -58.4% | -40.8% | -26.9% | -19.5% | -27.7% | -19.0% | -2.6% | 2.5% | -3.4% | -9.8% | -2.8% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.